{{Rsnum
|rsid=2017000
|Chromosome=7
|Orientation=plus
|geno1=(A;A)
|geno2=(A;G)
|geno3=(G;G)
|Gene=EGFR
|position=55174916
|Gene_s=EGFR
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
}}{{ population diversity
| geno1=(A;A)
| geno2=(A;G)
| geno3=(G;G)
| CEU | 49.6 | 40.7 | 9.7
| HCB | 16.9 | 54.4 | 28.7
| JPT | 10.6 | 49.6 | 39.8
| YRI | 87.1 | 12.9 | 0.0
| ASW | 82.5 | 12.3 | 5.3
| CHB | 16.9 | 54.4 | 28.7
| CHD | 14.7 | 52.3 | 33.0
| GIH | 26.7 | 55.4 | 17.8
| LWK | 93.6 | 6.4 | 0.0
| MEX | 43.9 | 43.9 | 12.3
| MKK | 81.4 | 17.9 | 0.6
| TSI | 53.9 | 35.3 | 10.8
| HapMapRevision=28
}}{{PMID Auto
|PMID=25217982
|Title=Essential role of polymorphism of Gab1, EGFR, and EGF for the susceptibility of biliary tract cancer
}}

{{on chip | 23andMe v1}}
{{on chip | 23andMe v2}}
{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}
{{on chip | FTDNA2}}
{{on chip | HumanOmni1Quad}}
{{on chip | Illumina Human 1M}}